Sanofi (NASDAQ:SNY) announced on Thursday that it plans to repurchase €5 billion ($5.21 billion) worth of shares this year and may take a more active approach to acquisitions in the near term. The ...

Advancements in technology have facilitated the production and distribution of larger quantities of counterfeited goods in shorter periods of time, and have made it easier for counterfeiters to profit ...

Sanofi said it will repurchase €5 billion ($5.2 billion) of stock and grow profits faster this year as the drugmaker pivots ...

After contending with another year of high food and labor costs, financially stressed consumers, and fierce competition, U.S. restaurant operators are approaching 2025 with a focus on engaging more ...

Amicus Therapeutics UK Limited , a patient-dedicated biotechnology company, today announced the launch of Amicus Ignite, a proactive community funding programme to support initiatives that advance ...